tradingkey.logo

DSS Inc

DSS
1.385USD
+0.015+1.09%
Close 09/29, 16:00ETQuotes delayed by 15 min
12.59MMarket Cap
LossP/E TTM

DSS Inc

1.385
+0.015+1.09%

More Details of DSS Inc Company

DSS, Inc. is a multinational, public company. It operates its business through six divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, Alternative Trading, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena. Digital Transformation serves as a Preferred Technology Partner and Application Development Solution for mid-cap brands across various industries.

DSS Inc Info

Ticker SymbolDSS
Company nameDSS Inc
IPO dateOct 27, 1993
CEOMr. Jason Grady
Number of employees100
Security typeOrdinary Share
Fiscal year-endOct 27
Address275 Wiregrass Pkwy
CityWEST HENRIETTA
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code14586
Phone15852321500
Websitehttps://www.dssworld.com/
Ticker SymbolDSS
IPO dateOct 27, 1993
CEOMr. Jason Grady

Company Executives of DSS Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
3.86M
77.98%
Commercial and Security Printing
135.00K
2.73%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
3.86M
77.98%
Commercial and Security Printing
135.00K
2.73%

Shareholding Stats

Updated: Fri, Aug 15
Updated: Fri, Aug 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
46.53%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.48%
Other
26.22%
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
46.53%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
Heuszel (Frank D.)
0.72%
Citadel Advisors LLC
0.48%
Other
26.22%
Shareholder Types
Shareholders
Proportion
Corporation
49.96%
Individual Investor
23.35%
Hedge Fund
0.94%
Investment Advisor
0.65%
Investment Advisor/Hedge Fund
0.21%
Other
24.89%

Institutional Shareholding

Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
41
5.38M
59.16%
+1.09K
2025Q1
42
5.38M
59.16%
+7.88K
2024Q4
44
5.34M
75.51%
+934.13K
2024Q3
50
4.36M
61.72%
-49.38K
2024Q2
55
4.37M
61.87%
-23.78K
2024Q1
58
4.35M
61.59%
-43.12K
2023Q4
57
4.38M
62.50%
-18.04K
2023Q3
61
4.33M
61.80%
-325.98K
2023Q2
66
4.33M
62.32%
-279.86K
2023Q1
73
4.27M
61.44%
-358.54K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Alset Ehome International Inc
3.65M
40.14%
--
--
Feb 26, 2025
Chan (Heng Fai Ambrose)
1.19M
13.06%
--
--
Feb 26, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Feb 26, 2025
Heuszel (Frank D.)
65.64K
0.72%
--
--
Feb 26, 2025
Citadel Advisors LLC
58.33K
0.64%
+58.33K
--
Mar 31, 2025
Renaissance Technologies LLC
26.25K
0.29%
+1.00K
+3.96%
Mar 31, 2025
The Vanguard Group, Inc.
21.73K
0.24%
-21.59K
-49.84%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
19.67K
0.22%
+7.16K
+57.24%
Mar 31, 2025
Ferguson Wellman Capital Management, Inc.
12.75K
0.14%
--
--
Mar 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
KeyAI